Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.
days to go:
Expired
investment:
£30,564
Auto Approval (FCA Approved) offer an alternative to PCP. They offer contract rental of new cars to customers with a less than perfect credit score. For those who do not have a sufficiently high credit rating for mainstream credit-driven automotive ownershop customers can enter the market if they have the ability to pay a monthly rental price.
days to go:
Expired
investment:
£3,460
The Bottled Bartender is a manufacturer of premium RTD cocktails. The company manufactures, markets, and distributes single-serve premium cocktails to the trade, events and home markets. The cocktails are designed with the same recipes as a high-end bar, by using only branded spirits, garden-fresh ingredients made by the experienced staff. The company wants Trade and Events to benefit from the speed of service and logistical ease and not hire specialist staff. The Bottled Bartender anticipates in using a 24-hour courier service.
days to go:
Expired
investment:
£61,150
World of Expats is a business designed to support expats with the tools, services and information they need to make the most of their live as an expat.
days to go:
Expired
investment:
£49,153
Doc2UK is a specialist UK medical recruitment and candidate support platform. Based in London, the platform places qualified doctors in the National Health Scheme (NHS) roles around the United Kingdom. The British Medical Association (2018) reported that patient care is at risk due to a critical shortage of doctors across multiple medical disciplines. At present, the UK only has 24 medical schools to fill this gap, whilst India, in comparison, has 468 medical schools, with 68,000 doctors graduating each year. Moreover, uncertainty about the status of EU nationals after Brexit, changes to immigration policies, and the impact of changing language testing requirements for international nurses have made this crisis worse. This situation necessitates recruiting doctors from overseas an important endeavour. This is where Doc2UK aims to become a key player and ensure that lack of medical personnel doesn't disrupt any medical services. The company is seeking an investment of up to £300,000 which will be used to develop the platform with more features, expand the team, marketing and sales.
days to go:
Expired
investment:
Withheld
UnderTheDoormat is an award-winning luxury home accommodation business offering guests a hotel quality experience in the comfort of a home. The company has had 59,000 guest bookings on its portal since 2017 across 350+ homes. UnderTheDoormat became the first company in the UK to be accredited by the government-backed 'Quality in Tourism Safe, Clean & Legal' scheme. In a post-COVID-19 world, the company finds itself uniquely placed to provide sanitised and safe homes for health workers and other individuals. UnderTheDoormat has grossed more than £4.7 million worth of gross booking revenue to date. The company will utilise the investment to expand its managed portfolio and develop larger B2B partnerships in the property industry.
days to go:
Expired
investment:
£332,400
